Back to Agenda
ON DEMAND - Artificial Intelligence: Use Cases from Real Trials
Session Chair(s)
Jane Elizabeth Myles, MSc
Program Director
Decentralized Trials and Research Alliance, United States
Artificial intelligence (AI) is a hot topic in drug development. While there is tremendous potential for AI to drive efficiency, very few ‘real life’ trial case studies to learn from. This session shares lessons and outcomes using AI in trials.
Learning Objective : Identify two to three applications for artificial intelligence (AI) to drive more efficient clinical operations decision making and execution; Describe two to three case studies of AI applications in planning or executing trials to drive efficiency through decreased resource utilization or increased speed; Summarize key learnings from case studies for application in next iteration use cases.
Speaker(s)
Panelist
Angela Radcliffe
Bristol-Myers Squibb Company , United States
Head, Data Governance and Stewardship
Panelist
Jonathan Crowther, PhD, MS
Pfizer Inc, Belgium
Site Intelligence Lead, Study Optimization, Global Product Development
Panelist
Sam De Brouwer
doc.ai, United States
Cofounder and COO
Have an account?